Finasteride and Masteron Interaction

Avoid
Researched 95% confidence

Finasteride and Masteron have a potentially harmful interaction with 95% confidence. Finasteride inhibits 5-alpha reductase, which converts testosterone to DHT. Since Masteron is already a DHT derivative, finasteride does not reduce its androgenic potency in any tissue. Furthermore, using finasteride while on Masteron is counterproductive: it will not protect against Masteron-induced hair loss (the primary reason for taking finasteride) and may worsen the overall androgenic side effect profile by altering the androgen balance. Individuals concerned about hair loss should avoid Masteron entirely rather than attempting to mitigate it with finasteride. These compounds primarily affect different organ systems.

Compound Profiles

Finasteride

5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH

Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).

Half-life: 6-8 hours (DHT suppression persists ~24 hours) Typical dose: 1mg/day (hair loss) or 5mg/day (BPH) hair loss
5 alpha reductase estrogenichepatotoxicteratogenic
View full profile

Masteron

DHT-Derived Anabolic Steroid | Hardening & Anti-Estrogenic

Drostanolone binds to the androgen receptor with high affinity, promoting protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme, eliminating estrogen-related side effects such as water retention and gynecomastia from the compound itself.

Half-life: ~2 days (propionate), ~10 days (enanthate) Typical dose: 300-500 mg/week anabolic
androgen receptoraromataseestrogen receptor androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

Combined Organ Load

Gonads
moderate
Heart
low
Skin
low
Liver
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Finasteride, Masteron). Monitor accordingly.

Frequently Asked Questions

Can I take Finasteride with Masteron?

Combining Finasteride with Masteron is not recommended. Finasteride inhibits 5-alpha reductase, which converts testosterone to DHT. Since Masteron is already a DHT derivative, finasteride does not reduce its androgenic potency in any tissue. Furthermore, using finasteride while on Masteron is counterproductive: it will not protect against Masteron-induced hair loss (the primary reason for taking finasteride) and may worsen the overall androgenic side effect profile by altering the androgen balance. Individuals concerned about hair loss should avoid Masteron entirely rather than attempting to mitigate it with finasteride.

Is Finasteride and Masteron safe together?

This combination carries significant risk. Finasteride inhibits 5-alpha reductase, which converts testosterone to DHT. Since Masteron is already a DHT derivative, finasteride does not reduce its androgenic potency in any tissue. Furthermore, using finasteride while on Masteron is counterproductive: it will not protect against Masteron-induced hair loss (the primary reason for taking finasteride) and may worsen the overall androgenic side effect profile by altering the androgen balance. Individuals concerned about hair loss should avoid Masteron entirely rather than attempting to mitigate it with finasteride. Consult a healthcare professional before combining.

What are the interactions between Finasteride and Masteron?

Finasteride inhibits 5-alpha reductase, which converts testosterone to DHT. Since Masteron is already a DHT derivative, finasteride does not reduce its androgenic potency in any tissue. Furthermore, using finasteride while on Masteron is counterproductive: it will not protect against Masteron-induced hair loss (the primary reason for taking finasteride) and may worsen the overall androgenic side effect profile by altering the androgen balance. Individuals concerned about hair loss should avoid Masteron entirely rather than attempting to mitigate it with finasteride. This assessment has 95% confidence and is based on documented research data.

How should I time Finasteride and Masteron?

Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours) and Masteron has a half-life of ~2 days (propionate), ~10 days (enanthate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Finasteride vs Masteron

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.